E. Hansvenclová

发表

Mid-term outcomes of patients with Lotus and Evolut transcatheter valves

J. Veselka, P. Hájek, E. Poláková, 2022, Postepy w kardiologii interwencyjnej = Advances in interventional cardiology.

Alcohol dose in septal ablation for hypertrophic obstructive cardiomyopathy.

H. Bundgaard, R. Stables, J. Veselka, 2021, International journal of cardiology.

Alcohol septal ablation in patients with severe septal hypertrophy

H. Bundgaard, J. Veselka, J. T. ten Berg, 2019, Heart.

Outcomes of Patients With Hypertrophic Obstructive Cardiomyopathy and Pacemaker Implanted After Alcohol Septal Ablation.

R. Stables, J. Veselka, P. Hansen, 2022, JACC. Cardiovascular interventions.

The impact of education as a marker of socio-economic status on survival of patients after transcatheter aortic valve implantation

J. Veselka, P. Hájek, R. Adlová, 2022, Postepy w kardiologii interwencyjnej = Advances in interventional cardiology.

Comparison of 30-Day Outcomes after Carotid Artery Stenting in Patients with Near-Occlusion and Severe Stenosis: A Propensity Score Matching Analysis

J. Veselka, P. Hájek, M. Horváth, 2022, American Journal of Neuroradiology.

High positive predictive value of PAPP-A for acute coronary syndrome diagnosis in heparin-naïve patients

M. Macek, J. Veselka, P. Hájek, 2012, Journal of Thrombosis and Thrombolysis.

Prediction of Sudden Cardiac Arrest After Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: ASA-SCARRE Risk Score.

R. Stables, J. Veselka, P. Hansen, 2022, The American journal of cardiology.

Long-term survival of carotid stenting patients with regard to single- or double-vessel carotid artery disease: a propensity score matching analysis

J. Veselka, P. Hájek, R. Roland, 2020, Archives of medical science : AMS.

Long-term outcome of repeated septal reduction therapy after alcohol septal ablation for hypertrophic obstructive cardiomyopathy: insight from the Euro-ASA registry

H. Bundgaard, J. Veselka, J. T. ten Berg, 2020, Archives of medical science : AMS.

Sex-Related Differences in Outcomes of Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy.

H. Bundgaard, J. Veselka, P. Hansen, 2021, JACC. Cardiovascular interventions.

Short- and long-term outcomes of alcohol septal ablation for hypertrophic obstructive cardiomyopathy in patients with mild left ventricular hypertrophy: a propensity score matching analysis.

H. Bundgaard, R. Stables, J. Veselka, 2019, European heart journal.

Outcomes of Alcohol Septal Ablation in Patients with Severe Left Ventricular Outflow Tract Obstruction: A Propensity Score Matching Analysis.

R. Stables, J. Veselka, J. T. ten Berg, 2023, The Canadian journal of cardiology.

Follow-Up of Up to 25 Years After Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy.

J. Veselka, D. Tesař, R. Adlová, 2023, JACC. Cardiovascular interventions.

Influence of concomitant heparin administration on pregnancy-associated plasma protein-A levels in acute coronary syndrome with ST segment elevation

M. Macek, J. Veselka, P. Hájek, 2011, Archives of medical science : AMS.